Pancreatic Cancer Research

ResearcherFibroGen (United States)Active in the last 2 years

Ewa Carrier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2225-5365; OpenAlex author ID A5006337596. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Neoadjuvant management of locally advanced pancreatic ductal adenocarcinoma - Heading towards a promising change in treatment paradigm. First author DOI 10.1016/j.ctrv.2024.102750↗
  2. A novel event-free survival endpoint in locally advanced pancreatic cancer. First author DOI 10.1177/17588359211059586↗
  3. Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer. Last author DOI 10.1136/esmoopen-2019-000668↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Umair Mahmood · 1 shared paper, 2024 · strength 0.36
  2. Khurum Hayat Khan · 1 shared paper, 2024 · strength 0.36
  3. Thomas Fleming · 1 shared paper, 2021 · strength 0.17
  4. Pascal R. Hammel · 1 shared paper, 2021 · strength 0.17
  5. Adnan A. Alseidi · 1 shared paper, 2020 · strength 0.10
  6. Flavio G. Rocha · 1 shared paper, 2020 · strength 0.10
  7. Jordan Michael Winter · 1 shared paper, 2020 · strength 0.10
  8. Kabir Mody · 1 shared paper, 2020 · strength 0.10
  9. Michael Jon Pishvaian · 1 shared paper, 2020 · strength 0.10
  10. Vincent J. Picozzi · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.